000 | 01931 a2200517 4500 | ||
---|---|---|---|
005 | 20250517010418.0 | ||
264 | 0 | _c20160105 | |
008 | 201601s 0 0 eng d | ||
022 | _a1476-5381 | ||
024 | 7 |
_a10.1111/bph.13047 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aKnapman, Alisa | |
245 | 0 | 0 |
_aA6V polymorphism of the human μ-opioid receptor decreases signalling of morphine and endogenous opioids in vitro. _h[electronic resource] |
260 |
_bBritish journal of pharmacology _cMay 2015 |
||
300 |
_a2258-72 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAdenylyl Cyclase Inhibitors _xpharmacology |
650 | 0 | 4 |
_aAdenylyl Cyclases _xmetabolism |
650 | 0 | 4 |
_aAnalgesics, Opioid _xpharmacology |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aBuprenorphine _xpharmacology |
650 | 0 | 4 | _aCHO Cells |
650 | 0 | 4 | _aCricetulus |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 |
_aEnkephalin, Ala(2)-MePhe(4)-Gly(5)- _xpharmacology |
650 | 0 | 4 |
_aFentanyl _xpharmacology |
650 | 0 | 4 |
_aG Protein-Coupled Inwardly-Rectifying Potassium Channels _xagonists |
650 | 0 | 4 | _aGenotype |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aIon Channel Gating _xdrug effects |
650 | 0 | 4 |
_aMitogen-Activated Protein Kinase 1 _xmetabolism |
650 | 0 | 4 |
_aMitogen-Activated Protein Kinase 3 _xmetabolism |
650 | 0 | 4 |
_aMorphine _xpharmacology |
650 | 0 | 4 | _aPhenotype |
650 | 0 | 4 | _aPhosphorylation |
650 | 0 | 4 | _aPolymorphism, Single Nucleotide |
650 | 0 | 4 |
_aReceptors, Opioid, mu _xagonists |
650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 | _aTransfection |
650 | 0 | 4 |
_abeta-Endorphin _xpharmacology |
700 | 1 | _aSantiago, Marina | |
700 | 1 | _aConnor, Mark | |
773 | 0 |
_tBritish journal of pharmacology _gvol. 172 _gno. 9 _gp. 2258-72 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1111/bph.13047 _zAvailable from publisher's website |
999 |
_c24469906 _d24469906 |